Type 1 Diabetes Virtual Self-management Education and Support (T1ME)
type1diabetes
About this trial
This is an interventional supportive care trial for type1diabetes
Eligibility Criteria
Inclusion Criteria: Outpatients ≥18 years of age Physician diagnosis of type 1 diabetes Currently on an insulin pump or using multiple daily insulin injections. HbA1c ≥ 8.0% on most recent laboratory report, within the last 4 months Has access to a mobile device or computer/tablet with a video camera Seen for at least one visit in the previous 6 months by participating certified diabetes educator at the selected diabetes clinic OR If a transitioning patient: Currently enrolled in a diabetes program below AND had at least one visit or touch-point prior in the previous 6 months by participating certified diabetes educator at on of our participating diabetes clinics OHIP coverage Currently using an active email address or be willing to obtain an email address Has consistent and reliable access to internet Willing and able to comply with scheduled in-person and virtual visits for 6 month intervention period Exclusion Criteria: Diagnosed with non-Type 1 diabetes Unable to use a computer/tablet or mobile phone Pregnant On dialysis Unable to fluently speak or read English (self-reported)
Sites / Locations
- Unity Health TorontoRecruiting
- Mount Sinai Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
High frequency, low-touch virtual health care
Standard Care
Participants in this arm will receive a high frequency, low-touch virtual health care intervention through the Maple application, as an adjunct to usual T1D care. High-frequency visits will occur every 2 +/- 1 weeks for a total of 6 months. Participants will also receive access to a virtual library to support T1D self-learning and as a guided educational tool.
Participants in this arm will receive the standard of care offered for their condition and by their clinic.